The Live Attenuated Vaccines community is comprised of individuals from different Institutions worldwide and includes the following members:
Roland Brosch obtained his PhD at the University of Salzburg in Austria and after some years of postdoctoral training at the University of Wisconsin in Madison and the Institut Pasteur in Paris, he integrated into the scientific staff of the Institut Pasteur in 2000. He is now Professor and Head of the Integrated Mycobacterial Pathogenomics Unit at the Institut Pasteur. He gained broad experience in mycobacterial research in the tuberculosis (TB) research field, where he had important impact on groundbreaking genome projects of Mycobacterium tuberculosis, the etiological agent of TB, the BCG vaccine, and the ancestral gene pool of TB-causing mycobacteria (Mycobacterium canettii). He was also involved in pioneering work on the evolution of the M. tuberculosis complex and the discovery and functional characterization of the ESX / type VII secretion system of M. tuberculosis. He continues to be very interested in these topics, which remain key issues for the identification of new virulence mechanisms of M. tuberculosis, for elucidating the extraordinary evolutionary success of M. tuberculosis, and for gaining new insights and perspectives into host-pathogen interaction, new vaccine concepts and therapeutic interventions.
Andreas Kupz is an NHMRC Career Development Fellow at the Australian Institute of Tropical Health and Medicine (AITHM) at James Cook University. Andreas completed his M.Sc. in biology at Humboldt-University in Berlin and a PhD in microbiology and immunology at the University of Melbourne. He performed his postdoctoral training at the Max-Planck Institute for Infection Biology in Germany as an NHMRC CJ Martin Research Fellow. His interests include microbiology, immunology and infectious disease epidemiology. Andreas’ research focuses on basic immunology and vaccine development for tuberculosis.